DNOW INC (DNOW) Stock Fundamental Analysis

NYSE:DNOW • US67011P1003

13.23 USD
-3.13 (-19.13%)
At close: Feb 20, 2026
13.31 USD
+0.08 (+0.6%)
After Hours: 2/20/2026, 8:04:00 PM
Fundamental Rating

5

DNOW gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 50 industry peers in the Trading Companies & Distributors industry. DNOW is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. A decent growth rate in combination with a cheap valuation! Better keep an eye on DNOW. These ratings could make DNOW a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • DNOW had positive earnings in the past year.
  • DNOW had a positive operating cash flow in the past year.
  • Of the past 5 years DNOW 4 years were profitable.
  • In multiple years DNOW reported negative operating cash flow during the last 5 years.
DNOW Yearly Net Income VS EBIT VS OCF VS FCFDNOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • With a decent Return On Assets value of 5.78%, DNOW is doing good in the industry, outperforming 62.00% of the companies in the same industry.
  • With a Return On Equity value of 8.12%, DNOW perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
  • DNOW has a better Return On Invested Capital (8.34%) than 68.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DNOW is in line with the industry average of 9.46%.
Industry RankSector Rank
ROA 5.78%
ROE 8.12%
ROIC 8.34%
ROA(3y)10.2%
ROA(5y)-2.26%
ROE(3y)15.11%
ROE(5y)-3.01%
ROIC(3y)9.52%
ROIC(5y)N/A
DNOW Yearly ROA, ROE, ROICDNOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • DNOW's Profit Margin of 3.95% is in line compared to the rest of the industry. DNOW outperforms 56.00% of its industry peers.
  • In the last couple of years the Profit Margin of DNOW has grown nicely.
  • The Operating Margin of DNOW (5.84%) is comparable to the rest of the industry.
  • DNOW's Operating Margin has improved in the last couple of years.
  • DNOW's Gross Margin of 23.11% is on the low side compared to the rest of the industry. DNOW is outperformed by 66.00% of its industry peers.
  • DNOW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.84%
PM (TTM) 3.95%
GM 23.11%
OM growth 3Y77.91%
OM growth 5Y29.34%
PM growth 3Y123.35%
PM growth 5YN/A
GM growth 3Y1.32%
GM growth 5Y2.76%
DNOW Yearly Profit, Operating, Gross MarginsDNOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DNOW is destroying value.
  • There is no outstanding debt for DNOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DNOW Yearly Shares OutstandingDNOW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DNOW Yearly Total Debt VS Total AssetsDNOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.74 indicates that DNOW is not in any danger for bankruptcy at the moment.
  • DNOW's Altman-Z score of 4.74 is fine compared to the rest of the industry. DNOW outperforms 80.00% of its industry peers.
  • There is no outstanding debt for DNOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.74
ROIC/WACC0.87
WACC9.63%
DNOW Yearly LT Debt VS Equity VS FCFDNOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • DNOW has a Current Ratio of 2.52. This indicates that DNOW is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.52, DNOW is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
  • DNOW has a Quick Ratio of 1.65. This is a normal value and indicates that DNOW is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.65, DNOW is doing good in the industry, outperforming 68.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 1.65
DNOW Yearly Current Assets VS Current LiabilitesDNOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The earnings per share for DNOW have decreased by -2.17% in the last year.
  • The Earnings Per Share has been decreasing by -1.79% on average over the past years.
EPS 1Y (TTM)-2.17%
EPS 3Y-1.79%
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%67.95%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.76% on average over the next years. This is quite good.
  • Based on estimates for the next years, DNOW will show a very strong growth in Revenue. The Revenue will grow by 21.72% on average per year.
EPS Next Y19.85%
EPS Next 2Y20.44%
EPS Next 3Y8.91%
EPS Next 5Y16.76%
Revenue Next Year92.57%
Revenue Next 2Y41.37%
Revenue Next 3Y-1.02%
Revenue Next 5Y21.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DNOW Yearly Revenue VS EstimatesDNOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
DNOW Yearly EPS VS EstimatesDNOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1

7

4. Valuation

4.1 Price/Earnings Ratio

  • DNOW is valuated correctly with a Price/Earnings ratio of 14.70.
  • 88.00% of the companies in the same industry are more expensive than DNOW, based on the Price/Earnings ratio.
  • DNOW's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • DNOW is valuated correctly with a Price/Forward Earnings ratio of 12.27.
  • 94.00% of the companies in the same industry are more expensive than DNOW, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.02, DNOW is valued rather cheaply.
Industry RankSector Rank
PE 14.7
Fwd PE 12.27
DNOW Price Earnings VS Forward Price EarningsDNOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DNOW is valued a bit cheaper than 64.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DNOW is valued cheaper than 88.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.88
EV/EBITDA 11.9
DNOW Per share dataDNOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • DNOW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y20.44%
EPS Next 3Y8.91%

0

5. Dividend

5.1 Amount

  • No dividends for DNOW!.
Industry RankSector Rank
Dividend Yield 0%

DNOW INC

NYSE:DNOW (2/20/2026, 8:04:00 PM)

After market: 13.31 +0.08 (+0.6%)

13.23

-3.13 (-19.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-20
Earnings (Next)05-05
Inst Owners61.39%
Inst Owner Change51.48%
Ins Owners1.41%
Ins Owner Change-0.03%
Market Cap2.46B
Revenue(TTM)N/A
Net Income(TTM)96.00M
Analysts84.44
Price Target18.02 (36.21%)
Short Float %4.71%
Short Ratio4.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.66%
Min EPS beat(2)9.25%
Max EPS beat(2)24.08%
EPS beat(4)4
Avg EPS beat(4)34.83%
Min EPS beat(4)9.25%
Max EPS beat(4)81.55%
EPS beat(8)6
Avg EPS beat(8)19.96%
EPS beat(12)8
Avg EPS beat(12)15%
EPS beat(16)12
Avg EPS beat(16)33.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)0.5%
Revenue beat(4)3
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.07%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)-1.06%
Revenue beat(16)9
Avg Revenue beat(16)-0.22%
PT rev (1m)0%
PT rev (3m)3.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)60.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)14.65%
Valuation
Industry RankSector Rank
PE 14.7
Fwd PE 12.27
P/S 1.01
P/FCF 13.88
P/OCF 12.66
P/B 2.08
P/tB 2.77
EV/EBITDA 11.9
EPS(TTM)0.9
EY6.8%
EPS(NY)1.08
Fwd EY8.15%
FCF(TTM)0.95
FCFY7.21%
OCF(TTM)1.04
OCFY7.9%
SpS13.1
BVpS6.37
TBVpS4.78
PEG (NY)0.74
PEG (5Y)N/A
Graham Number11.35
Profitability
Industry RankSector Rank
ROA 5.78%
ROE 8.12%
ROCE 11.59%
ROIC 8.34%
ROICexc 10.65%
ROICexgc 15.38%
OM 5.84%
PM (TTM) 3.95%
GM 23.11%
FCFM 7.28%
ROA(3y)10.2%
ROA(5y)-2.26%
ROE(3y)15.11%
ROE(5y)-3.01%
ROIC(3y)9.52%
ROIC(5y)N/A
ROICexc(3y)12.59%
ROICexc(5y)N/A
ROICexgc(3y)16.61%
ROICexgc(5y)N/A
ROCE(3y)13.24%
ROCE(5y)N/A
ROICexgc growth 3Y65.23%
ROICexgc growth 5Y25.7%
ROICexc growth 3Y55.27%
ROICexc growth 5Y26.13%
OM growth 3Y77.91%
OM growth 5Y29.34%
PM growth 3Y123.35%
PM growth 5YN/A
GM growth 3Y1.32%
GM growth 5Y2.76%
F-Score6
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40.48%
Cap/Sales 0.7%
Interest Coverage 250
Cash Conversion 105.44%
Profit Quality 184.38%
Current Ratio 2.52
Quick Ratio 1.65
Altman-Z 4.74
F-Score6
WACC9.63%
ROIC/WACC0.87
Cap/Depr(3y)46.41%
Cap/Depr(5y)37.91%
Cap/Sales(3y)0.51%
Cap/Sales(5y)0.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.17%
EPS 3Y-1.79%
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y19.85%
EPS Next 2Y20.44%
EPS Next 3Y8.91%
EPS Next 5Y16.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%67.95%
Revenue Next Year92.57%
Revenue Next 2Y41.37%
Revenue Next 3Y-1.02%
Revenue Next 5Y21.72%
EBIT growth 1Y8.4%
EBIT growth 3Y101.55%
EBIT growth 5Y23.83%
EBIT Next Year97.87%
EBIT Next 3Y59.73%
EBIT Next 5Y36.71%
FCF growth 1Y145.83%
FCF growth 3Y126.11%
FCF growth 5Y6.39%
OCF growth 1Y117.98%
OCF growth 3Y114.96%
OCF growth 5Y5.88%

DNOW INC / DNOW FAQ

What is the fundamental rating for DNOW stock?

ChartMill assigns a fundamental rating of 6 / 10 to DNOW.


What is the valuation status for DNOW stock?

ChartMill assigns a valuation rating of 6 / 10 to DNOW INC (DNOW). This can be considered as Fairly Valued.


What is the profitability of DNOW stock?

DNOW INC (DNOW) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for DNOW stock?

The Price/Earnings (PE) ratio for DNOW INC (DNOW) is 14.7 and the Price/Book (PB) ratio is 2.08.